Integreon Global, working through its business units – Cryopak, DDL and NexKemia – enables pharmaceutical companies to protect product integrity while eliminating cold-chain packaging waste—by closing ...
In the first part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, explains how ...
In today’s Pharma Pulse, HHS issues guidance for manufacturer-direct drug discounts, while clinical data warns of significant ...
More than a decade after the Drug Quality and Security Act (DQSA) of 2013 created the 503B category, the central question ...
Lastly, Insilico Medicine has inked a $120 million deal with Qilu Pharmaceuticals. The company will be using Insilico’s ...
Often referred to as AFPs, alternative funding programs are a third-party entity that works hand-in-hand with self-funded health plans to determine other ways to cover plan participants’ specialty ...
For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, ...
In today’s Pharma Pulse, global pharmaceutical production hits a surge as manufacturers brace for US tariff shifts, while a ...
Discover how access barriers evolve across the biopharma brand lifecycle, from launch to loss of exclusivity, and how to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results